دورية أكاديمية

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial

التفاصيل البيبلوغرافية
العنوان: Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
المؤلفون: Wang, FengAff1, Aff2, IDs41591024028131_cor1, Jin, YingAff1, Aff2, Wang, MinAff1, Aff2, Luo, Hui-YanAff1, Aff2, Fang, Wei-Jia, Wang, Ying-NanAff1, Aff2, Chen, Yan-XingAff1, Aff2, Huang, Run-JieAff1, Aff2, Guan, Wen-LongAff1, Aff2, Li, Ji-Bin, Li, Yu-HongAff1, Aff2, Wang, Feng-HuaAff1, Aff2, Hu, Xiao-Hua, Zhang, Yan-Qiao, Qiu, Miao-ZhenAff1, Aff2, Liu, Lu-Lu, Wang, Zi-XianAff1, Aff2, Ren, ChaoAff1, Aff2, Wang, De-ShenAff1, Aff2, Zhang, Dong-ShengAff1, Aff2, Wang, Zhi-QiangAff1, Aff2, Liao, Wen-Ting, Tian, Lin, Zhao, Qi, Xu, Rui-HuaAff1, Aff2, IDs41591024028131_cor25
المصدر: Nature Medicine. 30(4):1035-1043
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:10788956
1546170X
DOI:10.1038/s41591-024-02813-1